# Ur-Energy Inc: financial statements, quarterly

URG · NYSE · CIK 1375205 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/urg.md) · [Financials](/companies/urg/financials.md) · [Filings](/companies/urg/filings.md) · [Insiders](/companies/urg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/urg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.8](/filings/0001654954-24-013836.md) | [5.4 d](/filings/0001558370-25-004728.md) | [0.0](/filings/0001654954-24-005635.md) | [4.7](/filings/0001558370-25-010170.md) | [6.4](/filings/0001104659-25-105672.md) | [22.7 d](/filings/0001104659-26-025923.md) | not reported | [10.4](/filings/0001104659-26-093458.md) | [6.3](/filings/0001104659-25-105672.md) | [10.4 d](/filings/0001104659-26-025923.md) | [3.9](/filings/0001104659-26-057462.md) | [14.4](/filings/0001104659-26-093458.md) |
| Cost of revenue | $m | [4.9](/filings/0001654954-24-013836.md) | [5.1 d](/filings/0001558370-25-004728.md) | [1.1](/filings/0001558370-25-007006.md) | [3.3](/filings/0001558370-25-010170.md) | [5.6](/filings/0001104659-25-105672.md) | [32.6 d](/filings/0001104659-26-025923.md) | [2.6](/filings/0001104659-26-057462.md) | [8.5](/filings/0001104659-26-093458.md) | [7.1](/filings/0001104659-25-105672.md) | [9.0 d](/filings/0001104659-26-025923.md) | [2.7](/filings/0001104659-26-057462.md) | [12.5](/filings/0001104659-26-093458.md) |
| Gross profit | $m | [0.9](/filings/0001654954-24-013836.md) | [0.4 d](/filings/0001558370-25-004728.md) | [(1.1)](/filings/0001558370-25-007006.md) | [1.3](/filings/0001558370-25-010170.md) | [0.8](/filings/0001104659-25-105672.md) | [(9.9) d](/filings/0001104659-26-025923.md) | [(2.6)](/filings/0001104659-26-057462.md) | [1.9](/filings/0001104659-26-093458.md) | [(0.7)](/filings/0001104659-25-105672.md) | [1.5 d](/filings/0001104659-26-025923.md) | [1.2](/filings/0001104659-26-057462.md) | [1.9](/filings/0001104659-26-093458.md) |
| Operating income | $m | [(10.4)](/filings/0001654954-24-013836.md) | [(8.4) d](/filings/0001558370-25-004728.md) | [(16.3)](/filings/0001558370-25-007006.md) | [(11.4)](/filings/0001558370-25-010170.md) | [(11.9)](/filings/0001104659-25-105672.md) | [(23.5) d](/filings/0001104659-26-025923.md) | [(15.8)](/filings/0001104659-26-057462.md) | [(15.8)](/filings/0001104659-26-093458.md) | [(19.8)](/filings/0001104659-25-105672.md) | [(18.0) d](/filings/0001104659-26-025923.md) | [(20.3)](/filings/0001104659-26-057462.md) | [(18.4)](/filings/0001104659-26-093458.md) |
| Interest expense | $m | not reported | not reported | [0.1](/filings/0001558370-25-007006.md) | [0.0](/filings/0001558370-25-010170.md) | [0.0](/filings/0001104659-25-105672.md) | [0.1 d](/filings/0001104659-26-025923.md) | [0.3](/filings/0001104659-26-057462.md) | [0.3](/filings/0001104659-26-093458.md) | [0.4](/filings/0001104659-25-105672.md) | [1.0 d](/filings/0001104659-26-025923.md) | [2.9](/filings/0001104659-26-057462.md) | [2.8](/filings/0001104659-26-093458.md) |
| Net income | $m | [(17.2)](/filings/0001654954-24-013836.md) | [(5.5) d](/filings/0001558370-25-004728.md) | [(18.5)](/filings/0001558370-25-007006.md) | [(6.6)](/filings/0001558370-25-010170.md) | [(8.0)](/filings/0001104659-25-105672.md) | [(20.1) d](/filings/0001104659-26-025923.md) | [(10.9)](/filings/0001104659-26-057462.md) | [(21.0)](/filings/0001104659-26-093458.md) | [(27.5)](/filings/0001104659-25-105672.md) | [(15.6) d](/filings/0001104659-26-025923.md) | [(28.8)](/filings/0001104659-26-057462.md) | [(16.7)](/filings/0001104659-26-093458.md) |
| Diluted EPS | $ per share | [(0.07)](/filings/0001654954-24-013836.md) | not reported | [(0.07)](/filings/0001558370-25-007006.md) | [(0.02)](/filings/0001558370-25-010170.md) | [(0.02)](/filings/0001104659-25-105672.md) | not reported | [(0.03)](/filings/0001104659-26-057462.md) | [(0.06)](/filings/0001104659-26-093458.md) | [(0.07)](/filings/0001104659-25-105672.md) | not reported | [(0.07)](/filings/0001104659-26-057462.md) | [(0.04)](/filings/0001104659-26-093458.md) |
| Basic EPS | $ per share | [(0.07)](/filings/0001654954-24-013836.md) | not reported | [(0.07)](/filings/0001558370-25-007006.md) | [(0.02)](/filings/0001558370-25-010170.md) | [(0.02)](/filings/0001104659-25-105672.md) | not reported | [(0.03)](/filings/0001104659-26-057462.md) | [(0.06)](/filings/0001104659-26-093458.md) | [(0.07)](/filings/0001104659-25-105672.md) | not reported | [(0.07)](/filings/0001104659-26-057462.md) | [(0.04)](/filings/0001104659-26-093458.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [54.6](/filings/0001654954-24-013836.md) | [59.7](/filings/0001558370-25-004728.md) | [53.9](/filings/0001558370-25-007006.md) | [61.3](/filings/0001558370-25-010170.md) | [118](/filings/0001104659-25-105672.md) | [76.1](/filings/0001104659-26-025923.md) | [74.8](/filings/0001104659-26-057462.md) | [57.6](/filings/0001104659-26-093458.md) | [52.0](/filings/0001104659-25-105672.md) | [124](/filings/0001104659-26-093458.md) | [123](/filings/0001104659-26-057462.md) | [95.3](/filings/0001104659-26-093458.md) |
| Current assets | $m | [66.5](/filings/0001654954-23-013556.md) | [63.7](/filings/0001558370-25-004728.md) | [60.0](/filings/0001654954-24-005635.md) | [68.0](/filings/0001654954-24-010255.md) | [125](/filings/0001654954-24-013836.md) | [115](/filings/0001104659-26-025923.md) | [100.0](/filings/0001558370-25-007006.md) | [81.0](/filings/0001558370-25-010170.md) | [76.6](/filings/0001104659-25-105672.md) | [150](/filings/0001104659-26-093458.md) | [154](/filings/0001104659-26-057462.md) | [121](/filings/0001104659-26-093458.md) |
| Total assets | $m | [131](/filings/0001654954-23-013556.md) | [128](/filings/0001558370-25-004728.md) | [125](/filings/0001654954-24-005635.md) | [141](/filings/0001654954-24-010255.md) | [201](/filings/0001654954-24-013836.md) | [194](/filings/0001104659-26-025923.md) | [183](/filings/0001558370-25-007006.md) | [171](/filings/0001558370-25-010170.md) | [171](/filings/0001104659-25-105672.md) | [272](/filings/0001104659-26-093458.md) | [292](/filings/0001104659-26-057462.md) | [271](/filings/0001104659-26-093458.md) |
| Current liabilities | $m | [11.7](/filings/0001654954-23-013556.md) | [10.0](/filings/0001558370-25-004728.md) | [5.1](/filings/0001654954-24-005635.md) | [4.3](/filings/0001654954-24-010255.md) | [7.5](/filings/0001654954-24-013836.md) | [19.3](/filings/0001104659-26-025923.md) | [20.7](/filings/0001558370-25-007006.md) | [24.1](/filings/0001558370-25-010170.md) | [9.8](/filings/0001104659-25-105672.md) | [27.7](/filings/0001104659-26-093458.md) | [34.7](/filings/0001104659-26-057462.md) | [30.3](/filings/0001104659-26-093458.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [5.6](/filings/0001654954-23-013556.md) | [5.7](/filings/0001654954-24-013836.md) | [0.0](/filings/0001654954-24-005635.md) | [0.0](/filings/0001654954-24-010255.md) | [0.0](/filings/0001654954-24-013836.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [73.2](/filings/0001654954-24-013836.md) | [74.9](/filings/0001104659-26-025923.md) | [76.9](/filings/0001104659-25-105672.md) | [92.8](/filings/0001104659-25-105672.md) | [152](/filings/0001104659-25-105672.md) | [133](/filings/0001104659-26-093458.md) | [123](/filings/0001104659-26-093458.md) | [102](/filings/0001104659-26-093458.md) | [90.7](/filings/0001104659-25-105672.md) | [77.5](/filings/0001104659-26-093458.md) | [82.9](/filings/0001104659-26-093458.md) | [68.9](/filings/0001104659-26-093458.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(11.7) d](/filings/0001654954-24-013836.md) | [(0.3) d](/filings/0001558370-25-004728.md) | [(14.4)](/filings/0001558370-25-007006.md) | [(11.3) d](/filings/0001558370-25-010170.md) | [(6.8) d](/filings/0001104659-25-105672.md) | [(39.4) d](/filings/0001104659-26-025923.md) | [2.8](/filings/0001104659-26-057462.md) | [(12.1) d](/filings/0001104659-26-093458.md) | [(15.0) d](/filings/0001104659-25-105672.md) | [(18.8) d](/filings/0001104659-26-025923.md) | [(16.5)](/filings/0001104659-26-057462.md) | [(12.0) d](/filings/0001104659-26-093458.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001654954-24-013836.md) | [0.1 d](/filings/0001558370-25-004728.md) | [0.8](/filings/0001558370-25-007006.md) | [1.0 d](/filings/0001558370-25-010170.md) | [3.8 d](/filings/0001104659-25-105672.md) | [3.3 d](/filings/0001104659-26-025923.md) | [3.8](/filings/0001104659-26-057462.md) | [5.1 d](/filings/0001104659-26-093458.md) | [5.3 d](/filings/0001104659-25-105672.md) | [9.4 d](/filings/0001104659-26-025923.md) | [12.3](/filings/0001104659-26-057462.md) | [15.1 d](/filings/0001104659-26-093458.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [222](/filings/0001654954-23-013556.md) | [242](/filings/0001654954-24-005635.md) | [265](/filings/0001654954-24-010255.md) | [265](/filings/0001654954-24-013836.md) | [278](/filings/0001558370-25-007006.md) | [286](/filings/0001558370-25-010170.md) | [341](/filings/0001104659-25-105672.md) | [364](/filings/0001104659-26-057462.md) | [365](/filings/0001104659-26-093458.md) | [367](/filings/0001104659-25-105672.md) | [389](/filings/0001104659-26-057462.md) | [397](/filings/0001104659-26-093458.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 397,863,720 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093458.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.